Elixxer Ltd.
ELIXFOTCHealthcare● Active
$0.03
+$0.00(+0.00%)
Market Cap$23349740
P/E Ratio—
52W High$0.0991
52W Low$0.0013
Elixxer Ltd. (ELIXF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ELIXF · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2025Report Date: Nov 28, 2025EPS Actual
-$0.05
Revenue
—
Fiscal Period
Q4 FY2025
FY ends December
Report Date
Nov 28, 2025
After Market Close
ELIXF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | Jun 8, 2026 | — | — | — | — | — | — |
| — Q4 FY2025 | Nov 28, 2025 | — | -$0.05 | — | — | — | — |
| — Q3 FY2025 | Aug 29, 2025 | — | -$0.07 | — | — | — | — |
| — Q4 FY2024 | Nov 6, 2024 | — | -$0.04 | — | — | — | — |
| ◌ Q4 FY2024 | Oct 2, 2024 | — | — | — | — | — | — |
| ◌ Q3 FY2024 | Aug 30, 2024 | — | — | — | — | — | — |
| — Q4 FY2023 | Nov 24, 2023 | — | -$0.07 | — | — | — | — |
| — Q3 FY2023 | Jul 27, 2023 | — | -$0.05 | — | — | — | — |
Q2 FY2026
Jun 8, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2025
Nov 28, 2025
EPS Actual
-$0.05
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Aug 29, 2025
EPS Actual
-$0.07
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Nov 6, 2024
EPS Actual
-$0.04
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Oct 2, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 30, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 24, 2023
EPS Actual
-$0.07
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2023
Jul 27, 2023
EPS Actual
-$0.05
EPS Est.
—
EPS Surpr.
—
Revenue
—
No analyst estimates available for ELIXF.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2025 | Nov 28, 2025 | — | $0.01 | $0.01 | +0.00% |
| — Q3 FY2025 | Aug 29, 2025 | — | $0.00 | $0.00 | +0.00% |
| — Q4 FY2024 | Nov 6, 2024 | — | $0.01 | $0.01 | +0.00% |
| — Q4 FY2023 | Nov 24, 2023 | — | $0.03 | $0.01 | -81.46% |
| — Q3 FY2023 | Jul 27, 2023 | — | $0.03 | $0.01 | -81.46% |
| — Q2 FY2023 | Apr 19, 2023 | — | $0.03 | $0.03 | +0.00% |
| — Q2 FY2023 | Apr 8, 2023 | — | $0.03 | $0.03 | +0.00% |
| — Q3 FY2022 | Sep 29, 2022 | — | $0.80 | $0.80 | +0.00% |
Q4 FY2025+0.00%
Report Date
Nov 28, 2025
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q3 FY2025+0.00%
Report Date
Aug 29, 2025
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q4 FY2024+0.00%
Report Date
Nov 6, 2024
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q4 FY2023-81.46%
Report Date
Nov 24, 2023
EPS Beat/Miss
—
Price Before
$0.03
Price After
$0.01
Q3 FY2023-81.46%
Report Date
Jul 27, 2023
EPS Beat/Miss
—
Price Before
$0.03
Price After
$0.01
Q2 FY2023+0.00%
Report Date
Apr 19, 2023
EPS Beat/Miss
—
Price Before
$0.03
Price After
$0.03
Q2 FY2023+0.00%
Report Date
Apr 8, 2023
EPS Beat/Miss
—
Price Before
$0.03
Price After
$0.03
Q3 FY2022+0.00%
Report Date
Sep 29, 2022
EPS Beat/Miss
—
Price Before
$0.80
Price After
$0.80
Beat Rate0 / 8 quarters
Largest Move-81.46% (Q4 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ELIXF ends December
Elixxer Ltd. (ELIXF) most recently reported earnings on November 28, 2025 for Q4 FY2025, posting EPS of $-0.05 (in line with the analyst consensus of —). The next ELIXF earnings date is expected around September 1, 2026.
Each quarter, investors track ELIXF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ELIXF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ELIXF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ELIXF earnings · 4 questionsElixxer Ltd.'s next earnings report is expected around September 1, 2026. ELIXF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ELIXF historically reports after market close (AMC).
ELIXF earnings datewhen is ELIXF earningsELIXF next earnings datewhen does ELIXF report earningsELIXF earnings calendar
▸ Source: FMP · Elixxer Ltd. SEC filings · US GAAP · Elixxer Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026